Drugs and Devices

FDA approves new drug for Parkinson’s disease

On March 21, the U.S. Food and Drug Administration (FDA) approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares